| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |